Showing results (51-60 of 188) with videos related to
Sort By:
Pageof 19
Hepatitis Monthly|September 26, 2013
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-upShahnaz Sali, Seyed Moayed Alavian, Graham R Foster, et al.Cytokine|December 13, 2018
The protective effect of rifampicin on behavioral deficits, biochemical, and neuropathological changes in a cuprizone model of demyelinationHamid Zahednasab, Masoumeh Firouzi, Sussan Kaboudanian-Ardestani, et al.Journal of Neuroimmunology|June 12, 2017
Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: A population-based studySajad Karampoor, Hamid Zahednasab, Sreeram Ramagopalan, et al.Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2017
Human Papillomavirus (HPV) Genotype Distribution in Patients with Recurrent Respiratory Papillomatosis (RRP) in IranNegin Sadat Eftekhaar, Mohammad Hadi Karbalaie Niya, Farzad Izadi, et al.Heliyon|September 26, 2022
Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategyAli Salimi-Jeda, Maryam Esghaei, Hossein Keyvani, et al.Journal of Medical Virology|September 8, 2018
Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 miceAmir Hossein Mohseni, Vadood Razavilar, Hossein Keyvani, et al.Asian Pacific Journal of Cancer Prevention : APJCP|June 18, 2014
Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infectionVahdat Poortahmasebi, Seyed Moayed Alavian, Hossein Keyvani, et al.Heliyon|March 20, 2023
Corrigendum to "Inhibition of HIV-1 replication using the CRISPR/noNLS-Cas9 system as a prophylactic strategy"Ali Salimi-Jeda, Maryam Esghaei, Hossein Keyvani, et al.Analytica Chimica Acta|June 2, 2026
Bioluminescent label-free molecular switch for SARS-CoV-2 detectionZeynab Rezaei, Hossein Keyvani, Anne K Schütz, et al.Plos One|March 3, 2020
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individualsFarah Bokharaei-Salim, Maryam Esghaei, Khadijeh Khanaliha, et al.Pageof 19